Alexandre Perera

Title: Alexandre Perera: Innovator in Pharmaceutical Sciences

Introduction

Alexandre Perera is a notable inventor based in Ingelheim am Rhein, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the area of central nervous system diseases. His innovative work has led to the development of a specific compound that holds promise for various medical applications.

Latest Patents

Perera holds a patent for his invention titled "Difluoromethyl-phenyl triazoles". This patent describes difluoromethyl-phenyl triazoles of general formula (I), which serve as modulators of GABAreceptors containing the α5 subunit. These compounds are particularly useful in treating central nervous system diseases and other related conditions. The patent also outlines the processes for preparing pharmaceutical compositions and the manufacturing processes for the compounds based on this invention.

Career Highlights

Alexandre Perera is associated with Boehringer Ingelheim International GmbH, a leading global pharmaceutical company headquartered in Germany. His expertise in pharmaceutical sciences has been pivotal in advancing the company's research and development initiatives.

Collaborations

Throughout his career, Perera has collaborated with talented professionals in his field, including Janus Schreiber Larsen and Florian Binder. These partnerships highlight the importance of teamwork in driving innovation and creating effective solutions in healthcare.

Conclusion

Alexandre Perera stands out as an inventor dedicated to improving human health through innovative pharmaceuticals. His patent on difluoromethyl-phenyl triazoles represents a significant step forward in treating central nervous system diseases. With his continued contributions to Boehringer Ingelheim International GmbH and collaborations with esteemed colleagues, Perera is well-positioned to make further impactful advancements in the field.